My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > Etoposide phosphate (BMY-40481)

Etoposide phosphate (BMY-40481)

topoisomerase II inhibitor, BMY-40481, BMY40481, BMY 40481

Catalog No. Product Name Size List Price (US$) Quantity
APIM050404 Etoposide phosphate (BMY-40481) 25 mg 85.00
APIM050404 Etoposide phosphate (BMY-40481) 100 mg 250.00
Description

APIM050404: Etoposide phosphate (BMY-40481)

A potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor to prevent re-ligation of DNA strands. Etoposide phosphate is the phosphate ester prodrug of etoposide and is considered as active equivalent to Etoposide. Etoposide phosphate induces cell cycle arrest, apoptosis, and autophagy.
CAS No.: 117091-64-2
IUPAC/Chemical Name: [4-[(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-9-yl]-2,6-dimethoxyphenyl] dihydrogen phosphate
Molecular Formula: C29H33O16P
Molecular Weight: 668.54
Purity: 99% (HPLC)
QC: LC/MS, 1HNMR
Solubility: Soluble in DMSO and water
Storage: Store at 0 °C (short term), -20 °C (long term), Desiccated
Note: Please contact us for COA, Spectra, and SDS information.

Background Information:

Etoposide phosphate (BMY-40481) (CAS No.: 117091-64-2), a semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.

Target: Topoisomerase II

IC50: 0.945 μM (HCT116 FBXW+/+), 0.375 μM (HCT116 FBXW-/-), and 1.437 μM (HCT116 p53-/-)

In Vitro: Etoposide phosphate is a water-soluble derivative and probable prodrug of etoposide characterized by the presence of a phosphate group in position 4′ of the E ring of the etoposide molecule.[1]
Etoposide phosphate (0-1 μM; 72 hours) inhibits HCT116 FBXW+/+, FBXW-/- and p53-/- as a dose-dependent manner, exhibits IC50 values of 0.945 μM; 0.375 μM; and 1.437 μM"""

Related Links

See our Privacy Policy